GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Total Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Liabilities | ₹11,173 Cr | ₹10,611 Cr | ₹8,778 Cr | ₹7,834 Cr | ₹6,496 Cr |
What is the latest Total Liabilities ratio of GLAND PHARMA ?
Year | Total Liabilities |
---|---|
Mar2025 | ₹11,173 Cr |
Mar2024 | ₹10,611 Cr |
Mar2023 | ₹8,778 Cr |
Mar2022 | ₹7,834 Cr |
Mar2021 | ₹6,496 Cr |
How is Total Liabilities of GLAND PHARMA Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹11,173 Cr | 5.30 | |
Mar2024 | ₹10,611 Cr | 20.89 | |
Mar2023 | ₹8,778 Cr | 12.05 | |
Mar2022 | ₹7,834 Cr | 20.59 | |
Mar2021 | ₹6,496 Cr | - |
Compare Total Liabilities of peers of GLAND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAND PHARMA | ₹31,621.0 Cr | -1.9% | -5.1% | 13.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹396,862.0 Cr | 1.4% | 2.3% | -11.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹174,125.0 Cr | 7.1% | 8.8% | 10.3% | Stock Analytics | |
CIPLA | ₹125,454.0 Cr | 3.9% | -1.3% | -3.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,106.0 Cr | -1.3% | -1.3% | 2.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,263.0 Cr | 0.2% | -6% | -4.1% | Stock Analytics |
GLAND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAND PHARMA | -1.9% |
-5.1% |
13.4% |
SENSEX | 0.1% |
0.6% |
0.7% |
You may also like the below Video Courses